Trials / Unknown
UnknownNCT04090970
Briagen Observational Study
Briagen™ Case Study and Observation of Skin Excision Healing in Mohs and Other Dermatological Procedures
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Gemstone Biotherapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study is evaluating a study product called Briagen™ as a possible treatment for wound healing after Mohs procedure.
Detailed description
Briagen, the study product being used in this study, is a natural complex carbohydrate wound dressing for skin wounds created by Mohs surgery. Briagen was developed with the intent to improve healing time and reduce scarring of skin wounds. Briagen seeks to match the mechanical aspects of your skin (thickness, stiffness, hydration, pore size) to assist in the healing process. The purpose of this research study is to observe healing time of Briagen applied to wounds created as a result of Mohs surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Briagen | Natural complex carbohydrate wound dressing for skin wounds |
Timeline
- Start date
- 2019-08-26
- Primary completion
- 2020-03-01
- Completion
- 2020-05-01
- First posted
- 2019-09-16
- Last updated
- 2019-12-17
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04090970. Inclusion in this directory is not an endorsement.